Meet Dr. Garg

Hardesh Kumar Garg, M.D., the founder of Medisolare™ Wellness and Cosmetic Center, is the only physician in the Jacksonville area specializing in Anti-Aging Medicine, Sports Medicine and Non-surgical Cosmetic Enhancements - to make individuals of all ages feel and look younger, energetic and youthful.

Dr. Hardesh Garg, M.D., is a pioneer in the field of Integrated Medicine. His experience and expertise is unparalleled and his commitment to you ensures that you will always receive the very best in treatment and medical advice.

Dr Garg has experience working with professional and amateur athletes from different sports to increase their performance with this unique and individualized health and wellness program. He has worked with PGA Tour Golfer, Jaguar Football Player, many Tennis athletes and athletes from various other sports.

A pioneer in the field of complementary and alternative medicine/integrative medicine, he has designed and implemented a holistic, comprehensive and multi-disciplinary approach in managing several common diseases and disorders with programs for smoking cessation, stress, obesity and heart disease. This type of disease management protocol is unique from most programs found throughout the country, particularly in a primary care setting.

He is the only physician in the Jacksonville area specializing in the new and exciting specialty of non-surgical cosmetic enhancement - to make individuals look younger, slimmer and more beautiful without surgery.

Dr. Garg was the first to introduce mesotherapy to the Jacksonville area. He has safely performed thousands of Mesotherapy injections in the United States. His patients have had no infections or permanent side effects.

Affectionately known as “Dr. G” to his patients, the board-certified internal medicine specialist received his medical degree from the University of Delhi, India and completed post-graduate training in internal medicine from West Virginia University Health Sciences Center (Morgantown, WV) in 1993.

He has served as clinical assistant professor at the Department of Internal Medicine at the University of Florida School of Medicine and has also worked as a courtesy clinical assistant professor at the University of South Florida School of Medicine.

As a clinician, researcher, teacher, scientist and writer, Dr. G has been practicing medicine for more than 15 years. sub-investigator in a National Institute of Health-funded research study seeking genetic information on obesity.

He also serves as a member of the Medical Advisory Board of H Magazine, a publication of The Florida Times-Union, Jacksonville's daily newspaper. He also served as the national medical advisor for a national chain of weight loss centers.

He was also a speaker for major International Pharmaceutical companies like Pfizer and Bristol-Myers-Squibb.

Dr. G is well trained in the new and exciting specialty of cosmetic medicine and non-surgical cosmetic enhancement. He practices what he refers to as “integrated aesthetics,” essentially combining office-based, non-surgical procedures to make the skin look younger with a wellness approach to make skin function better. This is Medisolare's unique “beauty from inside out” program.

Dr. G is a member of Duval County Medical Society, American Academy of Aesthetic Medicine, American Academy of Anti-Aging Medicine and American Society for Laser Medicine and Surgery.

Visit us today for a complimentary introduction to the services that we offer and find out how we can "turn back the clock" on aging and restore your vitality and youthful appearance.

Call us today at 904-224-5000 to get more information about our unique products and programs or to make your complimentary appointment with Dr. Hardesh Garg, M.D.

Recent Publications:

Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations - John J. Lima(a), Hua Feng(b), Laurie Duckworth(a), Jianwei Wang(a), James E. Sylvester(a), Niranjan Kissoon(c), Hardesh Garg(d).

Metabolism Clinical and Experimental 56 (2007) 757– 765,Received 11 September 2006; accepted 2 January 2007

a Pharmacogenetics Center, Nemours Children’s Clinic, Jacksonville, FL 32207, USA
b Pharmacy Practice, University of Florida, Gainesville, FL 32610, USA
c Department of Pediatrics, British Columbia’s Children’s Hospital, Vancouver, British & Columbia, Canada V6H 3V4
d Medisolare Wellness and Cosmetic Center, Jacksonville, FL 32256, USA

Professional Presentations

• “Placement of PEG Tube Through Indwelling Esophageal Stent:, Read by title, American College of Physicians Meeting, January 1994
• “Acute Fulminant Hepatitis by Herpes Simplex Virus in Immunocompetent Host”,  American College of Physicians Meeting, January 1994
• “Overwhelming Postsplenectomy Sepsis by Capnocytophaga Canimorsus”, American College of Physicians Meeting , January 1992
• “Familial Papillary Thyroid Cancer”, American College of Physicians Meeting October 1990
• Influence of beta-2 receptor haplotype on Obesity ( October 2002), poster presentation: The American Society of Human Genetics( ASHG) 52nd Annual Meeting, Baltimore, Maryland, 2002.
• C.D.Crumel, J.Wang, H.Garg, J.Sylvester, J.J.Lima. Influence of beta-2 receptor haplotype on Obesity , American Journal of Human Genetics , October 2002; vol.71, (4), 369; Abstract 1122
• Influence of polymorphism on the beta1 and beta2 Adrenergic Receptor( beta1AR, Beta2 AR) Genes in ObesityPoster Presentation:  American College of Clinical Pharmacy Annual Meeting, Alburquerque,
  New Mexico.October 2002
• C.D.Crumel, J.Wang, H.Garg, J.Sylvester, J.J.Lima. Influence of polymorphism on the beta1 and beta2 Adrenergic Receptor ( beta1AR, Beta2 AR) Genes in Obesity,  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol 22, (10), 1390; ACCP Annual Meeting Abstract 386, 2002

Clinical Investigator:

• International VerapamilSR/Trandolapril Study (INVEST): A randomized, controlled clinical trial  comparing a calcium antagonist treatment strategy with a non-calcium antagonist treatment strategy for the control of hypertension in primary care coronary artery disease patients.
• Role of Beta 2 adrenergic receptors haplotypes in obesity. A NIH Funded Study.
• Design and Analysis of a Diet and Behavior Modification Program incorporating treatment with Xenical in Diabetes management program in Florida Medicaid patients. 

Principal Investigator

• A  placebo-controlled , double-blind trial to assess the efficacy and safety of Rofecoxib  in patients with chronic low back pain.
• A double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of inhaled Zanamivir in the treatment of Influenza A and B viral infections in subjects aged over 65.
• A randomized, double-blind, multicenter study to compare the efficacy, safety and tolerability of intravenous Gemifloxacin followed by oral gemifloxacin versus intravenous Levofloxacin followed by oral Levofloxacin in the treatment of hospitalized adult population with Community-Acquired Pneumonia
• Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril (OCTAVE) Trial
• A double-blind, multicenter study to compare the efficacy, safety and tolerability of intravenous Gemifloxacin followed by oral gemifloxacin versus intravenous Levofloxacin followed by oral Levofloxacin in the treatment of hospitalized adult population with nosocomial  pneumonia.